Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodor W May

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Expert Opinion on Pharmacotherapy|April 20, 2018
Extended-release drug formulations for the treatment of epilepsyChristian Brandt, Theodor W May
Epilepsia|May 25, 2002
The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Modular Service Package EpilepsyTheodor W May, Margarete Pfäfflin
Herzschrittmachertherapie & Elektrophysiologie|September 7, 2019
[Sudden unexpected death in epilepsy (SUDEP) : Epidemiology, cardiac and other risk factors]Theodor W May, Carsten W Israel
Therapeutic Drug Monitoring|May 22, 2002
Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Epilepsy & Behavior : E&B|April 7, 2015
Cognitive adverse events of topiramate in patients with epilepsy and intellectual disabilityChristian Brandt, Denise Lahr, Theodor W May
Seizure|September 13, 2015
Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapyAnnika Sattler, Marion Schaefer, Theodor W May
Epilepsia|June 7, 2016
Efficacy of the epilepsy nurse: Results of a randomized controlled studyMargarete Pfäfflin, Bettina Schmitz, Theodor W May
Therapeutic Drug Monitoring|November 26, 2003
Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Therapeutic Advances in Neurological Disorders|November 2, 2016
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence baseChristian Brandt, Theodor W May, Christian G Bien
Epilepsy & Behavior : E&B|December 24, 2018
Decreasing SUDEP incidence in a tertiary epilepsy center between 1981 and 2016: Effects of better patient supervisionReinhard Schulz, Christian G Bien, Theodor W May
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|April 20, 2018
Extended-release drug formulations for the treatment of epilepsyChristian Brandt, Theodor W May
Epilepsia|May 25, 2002
The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Modular Service Package EpilepsyTheodor W May, Margarete Pfäfflin
Herzschrittmachertherapie & Elektrophysiologie|September 7, 2019
[Sudden unexpected death in epilepsy (SUDEP) : Epidemiology, cardiac and other risk factors]Theodor W May, Carsten W Israel
Therapeutic Drug Monitoring|May 22, 2002
Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Epilepsy & Behavior : E&B|April 7, 2015
Cognitive adverse events of topiramate in patients with epilepsy and intellectual disabilityChristian Brandt, Denise Lahr, Theodor W May
Seizure|September 13, 2015
Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapyAnnika Sattler, Marion Schaefer, Theodor W May
Epilepsia|June 7, 2016
Efficacy of the epilepsy nurse: Results of a randomized controlled studyMargarete Pfäfflin, Bettina Schmitz, Theodor W May
Therapeutic Drug Monitoring|November 26, 2003
Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Therapeutic Advances in Neurological Disorders|November 2, 2016
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence baseChristian Brandt, Theodor W May, Christian G Bien
Epilepsy & Behavior : E&B|December 24, 2018
Decreasing SUDEP incidence in a tertiary epilepsy center between 1981 and 2016: Effects of better patient supervisionReinhard Schulz, Christian G Bien, Theodor W May
Pageof 9